REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,094 | +19.4% | 99 | +6.5% | 0.00% | – |
| Q1 2023 | $8,456 | +161.9% | 93 | +9.4% | 0.00% | – |
| Q4 2022 | $3,229 | +61.4% | 85 | +41.7% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 60 | -49.2% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 118 | -57.1% | 0.00% | – |
| Q1 2022 | $9,000 | +125.0% | 275 | +685.7% | 0.00% | – |
| Q3 2021 | $4,000 | -33.3% | 35 | -18.6% | 0.00% | – |
| Q2 2021 | $6,000 | +200.0% | 43 | +72.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 25 | +177.8% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 9 | -35.7% | 0.00% | – |
| Q3 2020 | $1,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |